FatiAbGen is a leading antibody engineering company developing best in class multi-modality antibodies for difficult targets in high unmet need disease in oncology and immunology. The leading asset is a superior anti-mesothelin ADC with unique characteristics and strong pre-clinical data.
FatiAbGen Co., Ltd.
Category:
Venture
Main Business Area
FatiAbGen is a company that focuses on innovating novel immunotoxin antibody assets and regulating stem cell fate with cutting-edge technologies.
| Contact Details | A-512~515, 6, Jiphyeonjungang 7-ro, Sejong-si +82-44-715-7707 |
|---|
Find out more companies
Related products
-
-
-
-
-
VentureAprogen
Their main modalities include SDR-Grafting, Recombinant Protein Fusion, CHIMPS Bispecific Antibodies, SHOCAP Bispecific Antibodies, and Bitargeting Receptor-Antibody Hybrid